Centrexion Therapeutics Corporation Made Big Gain

Centrexion Therapeutics Corporation (CNTX:NASDAQ) jumped higher at $1.06, representing a gain of 55.2%. On Tue, Jan 31, 2023, CNTX:NASDAQ hit a New 2-Week High of $1.06. The stock appeared on our News Catalysts scanner on Tue, Jan 31, 2023 at 07:53 AM in the 'BIOTECH' category. From Tue, Jan 17, 2023, the stock recorded 50.00% Up Days and 18.18% Green Days

The stock spiked on Tue, Jan 31, 2023 at $1.55 with a volume of 75M+.

About Centrexion Therapeutics Corporation (CNTX:NASDAQ)

Centrexion Therapeutics Corp is a late clinical-stage biopharmaceutical company. It is mainly engaged in identifying, developing and commercializing novel, non-opioid, non-addictive therapies to address the unmet medical need for the treatment of chronic pain. Its product candidate, CNTX-4975, is designed to selectively and locally target and disrupt the signaling of pain-sensing nerve fibers. Its other product candidate includes CNTX-0290, CNTX-6970, CNTX-2022, and CNTX-6016.